21 CFR 610.9
§ 610.9 Equivalent methods and processes.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 610.9, § 610.9 Equivalent methods and processes, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/88414
- Permanent ID
ys:prov:88414@1- SHA-256
0cc64b1c71bfeb2c80096fa11e27e36e644b0d2d70fc4c57040c0d566f1d39f6
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Modification of any particular test method or manufacturing process or the conditions under which it is conducted as required in this part or in the additional standards for specific biological products in parts 620 through 680 of this chapter shall be permitted only under the following conditions:
(a) The applicant presents evidence, in the form of a license application, or a supplement to the application submitted in accordance with § 601.12(b) or (c), demonstrating that the modification will provide assurances of the safety, purity, potency, and effectiveness of the biological product equal to or greater than the assurances provided by the method or process specified in the general standards or additional standards for the biological product; and
(b) Approval of the modification is received in writing from the Director, Center for Biologics Evaluation and Research or the Director, Center for Drug Evaluation and Research.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.